Income Statement for Pain Therapeutics (PTIE)

Income Statement for Pain Therapeutics
Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Profit
Total Revenue 41,119,000 10,890,000 11,484,000
Cost of Revenue - - -
Gross Profit 41,119,000 10,890,000 11,484,000
Operating Expenses
Research Development 4,917,000 7,605,000 8,300,000
Selling General and Administrative 4,837,000 7,182,000 6,698,000
Non Recurring - - -
Others - - -
Total Operating Expenses - - -
Operating Income or Loss 31,365,000 -3,897,000 -3,514,000
Income from Continuing Operations
Total Other Income/Expenses Net 106,000 451,000 901,000
Earnings Before Interest And Taxes 31,471,000 -3,446,000 -2,613,000
Interest Expense - - -
Income Before Tax 31,471,000 -3,446,000 -2,613,000
Income Tax Expense -73,000 - -
Minority Interest - - -
Net Income From Continuing Ops 31,544,000 -3,446,000 -2,613,000
Non-recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect Of Accounting Changes - - -
Other Items - - -
Net Income
Net Income 31,544,000 -3,446,000 -2,613,000
Preferred Stock And Other Adjustments - - -
Net Income Applicable To Common Shares 31,544,000 -3,446,000 -2,613,000